Alejandra Carvajal
CIK: 0001645755
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (25 total)
- Aug 3, 2026CTMX
CytomX Therapeutics, Inc.
Award(A)Direct100K shares- - Jan 6, 2026MRSN
Mersana Therapeutics, Inc.
Disposition(D)DirectRestricted Stock Units
2.2K shares- - Jan 6, 2026MRSN
Mersana Therapeutics, Inc.
Disposition(D)DirectStock Option (right to buy)
3K shares- - Jan 6, 2026MRSN
Mersana Therapeutics, Inc.
Disposition(D)DirectStock Option (right to buy)
6.7K shares- - Jan 6, 2026MRSN
Mersana Therapeutics, Inc.
Disposition(D)DirectStock Option (right to buy)
4.5K shares- - Jan 6, 2026MRSN
Mersana Therapeutics, Inc.
Disposition(D)DirectStock Option (right to buy)
1.8K shares- - Jan 6, 2026MRSN
Mersana Therapeutics, Inc.
Disposition(D)DirectStock Option (right to buy)
1.5K shares- - Jan 6, 2026MRSN
Mersana Therapeutics, Inc.
Disposition(D)DirectStock Option (right to buy)
4.9K shares- - Jan 6, 2026MRSN
Mersana Therapeutics, Inc.
Disposition(D)DirectStock Option (right to buy)
1.1K shares- - Jan 6, 2026MRSN
Mersana Therapeutics, Inc.
Disposition(D)DirectStock Option (right to buy)
7.9K shares- - Jan 6, 2026MRSN
Mersana Therapeutics, Inc.
Disposition(D)DirectRestricted Stock Units
100 shares- - Jan 6, 2026MRSN
Mersana Therapeutics, Inc.
Disposition(D)DirectRestricted Stock Units
717 shares- - Jan 6, 2026MRSN
Mersana Therapeutics, Inc.
Disposition(D)DirectRestricted Stock Units
1.5K shares- - Jan 6, 2026MRSN
Mersana Therapeutics, Inc.
Tender Offer(U)Direct3.1K shares- - Jan 16, 2025MRSN
Mersana Therapeutics, Inc.
Sale(S)Direct5.1K shares at avg. $0.58$3K - Jan 15, 2025MRSN
Mersana Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
243.8K shares- - Jan 15, 2025MRSN
Mersana Therapeutics, Inc.
Award(A)DirectRestricted Stock Unit
54.2K shares- - Jan 15, 2025MRSN
Mersana Therapeutics, Inc.
Exercise(M)Direct12.5K shares- - Jan 15, 2025MRSN
Mersana Therapeutics, Inc.
Sale(S)Direct952 shares at avg. $0.63$599.76 - Jan 14, 2025MRSN
Mersana Therapeutics, Inc.
Exercise(M)Direct2.5K shares- - Jan 14, 2025MRSN
Mersana Therapeutics, Inc.
Sale(S)Direct3.3K shares at avg. $0.66$2K - Jan 13, 2025MRSN
Mersana Therapeutics, Inc.
Exercise(M)Direct9K shares- - Oct 3, 2024MRSN
Mersana Therapeutics, Inc.
Sale(S)Direct5.6K shares at avg. $1.96$11K - Oct 2, 2024MRSN
Mersana Therapeutics, Inc.
Sale(S)Direct8.1K shares at avg. $2.00$16K - Oct 1, 2024MRSN
Mersana Therapeutics, Inc.
Exercise(M)Direct50K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 3, 2026 |  CTMX CytomX Therapeutics, Inc. | Award(A) | 100,000 | - | $0 | Direct |
| Jan 6, 2026 |  MRSN Mersana Therapeutics, Inc. | Disposition(D) Restricted Stock Units | 2,166 | - | - | Direct |
| Jan 6, 2026 | MRSN Mersana Therapeutics, Inc. | Disposition(D) Stock Option (right to buy) | 3,047 | - | - | Direct |
| Jan 6, 2026 | MRSN Mersana Therapeutics, Inc. | Disposition(D) Stock Option (right to buy) | 6,702 | - | - | Direct |
| Jan 6, 2026 | MRSN Mersana Therapeutics, Inc. | Disposition(D) Stock Option (right to buy) | 4,500 | - | - | Direct |
| Jan 6, 2026 | MRSN Mersana Therapeutics, Inc. | Disposition(D) Stock Option (right to buy) | 1,800 | - | - | Direct |
| Jan 6, 2026 | MRSN Mersana Therapeutics, Inc. | Disposition(D) Stock Option (right to buy) | 1,527 | - | - | Direct |
| Jan 6, 2026 | MRSN Mersana Therapeutics, Inc. | Disposition(D) Stock Option (right to buy) | 4,922 | - | - | Direct |
| Jan 6, 2026 | MRSN Mersana Therapeutics, Inc. | Disposition(D) Stock Option (right to buy) | 1,078 | - | - | Direct |
| Jan 6, 2026 | MRSN Mersana Therapeutics, Inc. | Disposition(D) Stock Option (right to buy) | 7,921 | - | - | Direct |
| Jan 6, 2026 | MRSN Mersana Therapeutics, Inc. | Disposition(D) Restricted Stock Units | 100 | - | - | Direct |
| Jan 6, 2026 | MRSN Mersana Therapeutics, Inc. | Disposition(D) Restricted Stock Units | 717 | - | - | Direct |
| Jan 6, 2026 | MRSN Mersana Therapeutics, Inc. | Disposition(D) Restricted Stock Units | 1,500 | - | - | Direct |
| Jan 6, 2026 | MRSN Mersana Therapeutics, Inc. | Tender Offer(U) | 3,131 | - | $0 | Direct |
| Jan 16, 2025 | MRSN Mersana Therapeutics, Inc. | Sale(S) | 5,096 | $0.58 | $2,956 | Direct |
| Jan 15, 2025 | MRSN Mersana Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 243,750 | - | - | Direct |
| Jan 15, 2025 | MRSN Mersana Therapeutics, Inc. | Award(A) Restricted Stock Unit | 54,167 | - | - | Direct |
| Jan 15, 2025 | MRSN Mersana Therapeutics, Inc. | Exercise(M) | 12,500 | - | $0 | Direct |
| Jan 15, 2025 | MRSN Mersana Therapeutics, Inc. | Sale(S) | 952 | $0.63 | $600 | Direct |
| Jan 14, 2025 | MRSN Mersana Therapeutics, Inc. | Exercise(M) | 2,500 | - | $0 | Direct |
| Jan 14, 2025 | MRSN Mersana Therapeutics, Inc. | Sale(S) | 3,330 | $0.66 | $2,198 | Direct |
| Jan 13, 2025 | MRSN Mersana Therapeutics, Inc. | Exercise(M) | 8,958 | - | $0 | Direct |
| Oct 3, 2024 | MRSN Mersana Therapeutics, Inc. | Sale(S) | 5,598 | $1.96 | $10,972 | Direct |
| Oct 2, 2024 | MRSN Mersana Therapeutics, Inc. | Sale(S) | 8,089 | $2.00 | $16,178 | Direct |
| Oct 1, 2024 | MRSN Mersana Therapeutics, Inc. | Exercise(M) | 50,000 | - | $0 | Direct |
1-25 of 25 transactions
About Carvajal Alejandra
Carvajal Alejandra (SEC CIK 0001645755) files insider reports with the SEC as Chief Legal Officer of CytomX Therapeutics, Inc. (CTMX) and SVP, Chief Legal Officer of Mersana Therapeutics, Inc. (MRSN).
Signal8 holds 7 ownership filings by Carvajal Alejandra (1 Form 3, 6 Form 4), filed between Oct 7, 2024 and Aug 5, 2026. Those filings report 25 transactions, from Oct 1, 2024 to Aug 3, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Carvajal Alejandra's filings is in SOUTH SAN FRANCISCO, CA.
Recent filings by Carvajal Alejandra
- Aug 3, 2026: Grant or award of CTMX shares (Form 4, code A).
- Jan 6, 2026: Disposition to issuer transactions of MRSN derivative securities (12 lines, Form 4, code D).
- Jan 6, 2026: Tender of shares transaction of MRSN shares (Form 4, code U).
- Jan 16, 2025: Open-market sale of MRSN shares (Form 4, code S).
- Jan 15, 2025: Grants or awards of MRSN derivative securities (2 lines, Form 4, code A).
Other insiders filing for CytomX Therapeutics, Inc. (CTMX)
- McCarthy Sean A., CEO
- Fuchs Charles S., Director
- Su Zhen, Director
- Young Matthew P., Director
- Mohindru Mani, Director
- Meyers James R, Director